| Autor: |
Gasch-Illescas A; Service de Santé Étudiants, Campus Arras, University of Artois, 62000 Arras, France.; Escuela Internacional de Doctorado, University of Seville, 41004 Seville, Spain.; Infectious and Immune System Diseases, Epidemiology and Public Health, Instituto de Biomedicina de Sevilla, IBIS, Hospital Universitario Virgen del Rocío, CSIC, University of Seville, 41013 Seville, Spain., Andrade-Arroyo M; Servicio de Medicina Interna, Hospital Universitario Virgen del Rocío, 41013 Sevilla, Spain., Vallejo-Vaz AJ; Department of Medicine, Faculty of Medicine, University of Seville, 41013 Seville, Spain.; Clinical Epidemiology and Vascular Risk, Instituto de Biomedicina de Sevilla, IBIS, Hospital Universitario Virgen del Rocío, Consejo Superior de Investigaciones Científicas, CSIC, University of Seville, 41013 Seville, Spain., Praena-Fernández JM; Department of Statistics and Operations Research, University of Granada, 18071 Granada, Spain., Guerrero JA; Servicio de Documentación Clínica, Hospital Universitario Virgen del Rocío, 41013 Seville, Spain., Calderón EJ; Clinical Epidemiology and Vascular Risk, Instituto de Biomedicina de Sevilla, IBIS, Hospital Universitario Virgen del Rocío, Consejo Superior de Investigaciones Científicas, CSIC, University of Seville, 41013 Seville, Spain.; Instituto de Biomedicina de Sevilla, IBIS, HUVR, Junta de Andalucía, Consejo Superior de Investigaciones Científicas, CSIC, University of Seville, 41013 Seville, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain., Pollán M; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain.; National Center for Epidemiology, Instituto de Salud Carlos III ES, 28029 Madrid, Spain., Medrano FJ; Clinical Epidemiology and Vascular Risk, Instituto de Biomedicina de Sevilla, IBIS, Hospital Universitario Virgen del Rocío, Consejo Superior de Investigaciones Científicas, CSIC, University of Seville, 41013 Seville, Spain.; Instituto de Biomedicina de Sevilla, IBIS, HUVR, Junta de Andalucía, Consejo Superior de Investigaciones Científicas, CSIC, University of Seville, 41013 Seville, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain. |
| Abstrakt: |
In 2020, Spain ranked fourth among European countries with the highest excess mortality due to COVID-19 disease. This study evaluates the impact of the COVID-19 pandemic on non-COVID patients in a tertiary hospital during the second pandemic wave in Spain (22 June 2020-6 December 2020). Data from Virgen del Rocío University Hospital in Seville during that timeframe were compared with the data from the same period in the preceding two years (2018-2019). Between-group comparisons were performed using the Chi-squared test, Student's t -test, or Mann-Whitney U tests, as appropriate. A total of 63,137 non-COVID patients were included in this study. During the second pandemic wave, a 19% decrease was observed in the annual number of non-COVID admissions overall (18,260 vs. 22,439, p < 0.001), but a 10% increase in the proportion of emergency admissions (60.6% vs. 54.93%, p < 0.001), a higher severity level of patients (1.79 vs. 1.72, p < 0.001), a longer in-hospital stay (7.02 vs. 6.74 days, p < 0.001), a 26% increase in non-COVID mortality (4.9% vs. 3.9%, p < 0.001), and a 50% increase in global mortality (5.9 vs. 3.9, p < 0.001) were also observed. In terms of both medical and surgical diagnoses, a significant reduction in the number of admissions and an increase in in-hospital mortality were observed. These results demonstrate the significant impact of the pandemic on hospital care, similar to what was previously observed during the initial wave in the same hospital. Our findings emphasize the need to include non-COVID patients when assessing the broad impact of the pandemic on healthcare, beyond its direct effects on COVID-19 patients. |
